FDA approves Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
Listen to an audio podcast of the July 26, 2019 FDA Drug Safety Communication on FDA approval of Boxed Warning about increased risk of blood clots and death with higher dose of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - August 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

Filgotinib for Treatment-Resistant Rheumatoid Arthritis, Intensive vs Standard Glucose Management in Acute Stroke, Neuroimaging Finding in US Cuban Government Personnel, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 23, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 23, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts

Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts

John Tesser, MD, FACP, FACR - Overcoming Challenges in the Management of Refractory Rheumatoid Arthritis: Expert Insight on the Clinical Potential of Novel Therapeutic Options
Go online to PeerView.com/XQR860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in rheumatology discusses the role of novel therapeutic options in overcoming challenges associated with the management of patients with refractory rheumatoid arthritis. Upon completion of this activity, participants should be better able to: Recognize challenges associated with the management of refractory rheumatoid arthritis, Identify novel therapeutic options for rheumatoid arthritis in the context of mechanism of action, efficacy, and safety, Employ current ev...
Source: PeerView CME/CE Audio Podcast - Immunology - May 14, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Leonard H. Calabrese, DO - Rheumatology, Immunology, and Immuno-Oncology Intersect: Navigating the Complexities of Immune Checkpoint Inhibition, Autoimmunity, and Immune-Related Adverse Events: How Can Rheumatologists Help Minimize the Risks and Maximize the Benefits of Cancer Immunotherapies?
Go online to PeerView.com/GQF860 to view the entire program with slides.In this video panel discussion, Leonard H. Calabrese, DO, and Evan J. Lipson, MD, engage in an interdisciplinary discussion of why it is important for rheumatologists to have a good grasp of immuno-oncology (IO) in general and of the unique immune-related adverse events (irAEs) associated with cancer immunotherapies in particular. They explore the new class of immune checkpoint inhibitors, how they work, in which cancer types they’re used, why and how irAEs develop, and which rheumatic irAEs can occur as part of the broad spectrum of potential ir...
Source: PeerView CME/CE Audio Podcast - Immunology - April 12, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

FDA Drug Safety Podcast: Safety trial finds risk of blood clots in the lungs and death with higher dose of tofacitinib (Xeljanz, Xeljanz XR) in rheumatoid arthritis patients; FDA to investigate
On February 25, 2019 FDA alerted the public that a safety clinical trial found an increased risk of blood clots in the lungs and death when a 10 mg twice daily dose of tofacitinib (brand names Xeljanz, Xeljanz XR) was used in patients with rheumatoid arthritis (or RA). (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - March 5, 2019 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts

"Absorbing News" -- The Discovery Files
Engineers at the University of California, San Diego, have developed "nanosponges" that can safely absorb and neutralize a variety of proteins that play a role in the progression of rheumatoid arthritis. Injections of these nanosponges effectively treated severe rheumatoid arthritis in two mouse models, and administering the nanosponges early on prevented the disease from developing. (Source: The Discovery Files)
Source: The Discovery Files - February 7, 2019 Category: Science Authors: National Science Foundation Source Type: podcasts

Randy Q. Cron, MD, PhD - Systemic Juvenile Idiopathic Arthritis: A Closer Look at the Burden on Patients and Caregivers From Diagnosis to Treatment
Systemic Juvenile Idiopathic Arthritis: A Closer Look at the Burden on Patients and Caregivers From Diagnosis to Treatment (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - January 17, 2019 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Randy Q. Cron, MD, PhD - Systemic Juvenile Idiopathic Arthritis: A Closer Look at the Burden on Patients and Caregivers From Diagnosis to Treatment
Systemic Juvenile Idiopathic Arthritis: A Closer Look at the Burden on Patients and Caregivers From Diagnosis to Treatment (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - January 17, 2019 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Medicare's HRRP and Mortality, Knee Arthritis Pain Control, Management of In-Flight Medical Emergencies, Best of Graphic Medicine 2018, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 21, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - December 21, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts

William F. C. Rigby, MD - Improving Outcomes for Patients With Refractory Rheumatoid Arthritis: The Role of JAK Inhibitors
Improving Outcomes for Patients With Refractory Rheumatoid Arthritis: The Role of JAK Inhibitors (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - October 13, 2018 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Surgery vs. Physical Therapy for Meniscal Tears, Treatment of Subclinical Hypothyroidism, Fauci on Tuberculosis, Rheumatoid Arthritis Review, and more
Editor's Summary by Phil Fontanarosa, MD, Executive Editor of JAMA, the Journal of the American Medical Association, for the October 02, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - October 2, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Treating Back and Arthritis Pain With Opioids, Effects of 1-time PSA Screening on Prostate Cancer Mortality, Evidence for Using Vitamin and Mineral Supplements, Management of Thyroid Nodules, and more
Editor's Summary by Edward H. Livingston, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the March 6, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 6, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

'Avoid Opioids to Treat Arthritis,' Says a Rheumatologist
Rheumatologic conditions can be treated effectively without the use of opioids, says Dr Jonathan Kay. (Source: Medscape Medscape Podcast)
Source: Medscape Medscape Podcast - January 3, 2018 Category: General Medicine Authors: Medscape Source Type: podcasts

Withdrawing Therapy in Patients With Arthritis
Dr Jonathan Kay reviews three studies evaluating three different withdrawal strategies for patients with arthritis, from the ACR/ARHP Annual Meeting. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - December 12, 2017 Category: Rheumatology Authors: Medscape Source Type: podcasts

From San Diego, A Great Debate on Biosimilars
Dr Jonathan Kay provides an overview of news and views on biosimilars to be presented at ACR 2017. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 22, 2017 Category: Rheumatology Authors: Medscape Source Type: podcasts

Repurposed HIV and arthritis drugs in the treatment of leukaemia
Steven T. Rosen, MD, from the City of Hope, Duarte, CA, discusses novel conceptual treatment approaches at the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada. A n... Author: VJHemOnc Added: 11/21/2017 (Source: Oncology Tube)
Source: Oncology Tube - November 21, 2017 Category: Cancer & Oncology Source Type: podcasts

William F.C. Rigby, MD - JAK Inhibitors in Rheumatoid Arthritis: Aligning Pathophysiology, Treatment Advances, and Patient Preference Into a Personalized Approach to Care for Improved Outcomes
JAK Inhibitors in Rheumatoid Arthritis: Aligning Pathophysiology, Treatment Advances, and Patient Preference Into a Personalized Approach to Care for Improved Outcomes (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - October 11, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Timothy Beukelman, MD, MSCE - Systemic Juvenile Idiopathic Arthritis: Overcoming Challenges in Diagnosis and Management to Individualize Care and Achieve Treatment Goals
Systemic Juvenile Idiopathic Arthritis: Overcoming Challenges in Diagnosis and Management to Individualize Care and Achieve Treatment Goals (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - October 10, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Alan J. Kivitz, MD, CPI - Addressing Unmet Needs in Rheumatoid Arthritis Through Novel Treatment Options and Enhanced Physician –Patient Collaboration
Addressing Unmet Needs in Rheumatoid Arthritis Through Novel Treatment Options and Enhanced Physician–Patient Collaboration (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - September 6, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Echo Case: Why Is There Dyspnea? Start With the Doppler
Dr Wharton narrates a case of a patient with a history or rheumatic heart disease. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 25, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts

Echo Case: Why Is There Dyspnea? Start With the Doppler
Dr Wharton narrates a case of a patient with a history of rheumatic heart disease. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - August 25, 2017 Category: Cardiology Authors: Medscape Source Type: podcasts

A jump in rates of knee arthritis, a brief history of eclipse science, and bands and beats in the atmosphere of brown dwarfs
This week we hear stories on a big jump in U.S. rates of knee arthritis, some science hits and misses from past eclipses, and the link between a recently discovered thousand-year-old Viking fortress and your Bluetooth earbuds with Online News Editor David Grimm. Sarah Crespi talks to Daniel Apai about a long-term study of brown dwarfs and what patterns in the atmospheres of these not-quite-stars, not-quite-planets can tell us. Listen to previous podcasts. [Image: NASA/JPL-Caltech; Music: Jeffrey Cook]   (Source: Science Magazine Podcast)
Source: Science Magazine Podcast - August 17, 2017 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Philip J. Mease, MD, MACR - Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis: A Closer Look at the Importance of Early Diagnosis and Role of New Treatment Options
Optimizing Outcomes Throughout the Journey of Patients With Psoriatic Arthritis: A Closer Look at the Importance of Early Diagnosis and Role of New Treatment Options (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - August 7, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Glenn J. Jaffe, MD - Improving Outcomes in Patients with Uveitis: Strengthening the Connection Between Ophthalmologists and Rheumatologists in an Era of New Treatment Options
Improving Outcomes in Patients with Uveitis: Strengthening the Connection Between Ophthalmologists and Rheumatologists in an Era of New Treatment Options (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - June 26, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Rheumatoid arthritis: The Lancet: June 19, 2017
A special podcast from the European League Against Rheumatology meeting in Madrid, highlighting a two-part Series on rheumatoid arthritis. (Source: Listen to The Lancet)
Source: Listen to The Lancet - June 20, 2017 Category: General Medicine Authors: The Lancet Source Type: podcasts

Leonard H. Calabrese, DO - Biosimilars in Rheumatoid Arthritis: What Does a Changing Treatment Landscape Mean for You and Your Patients?
Biosimilars in Rheumatoid Arthritis: What Does a Changing Treatment Landscape Mean for You and Your Patients? (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - May 11, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Roy Fleischmann, MD, MACR - Novel Options and Patient Perspectives in Rheumatoid Arthritis: Individualizing Care for Therapeutic Success
Novel Options and Patient Perspectives in Rheumatoid Arthritis: Individualizing Care for Therapeutic Success (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - April 8, 2017 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Leonard H. Calabrese, DO - Assessing the Latest Research in Psoriatic Arthritis Management: Clinical Highlights From Washington, DC
Assessing the Latest Research in Psoriatic Arthritis Management: Clinical Highlights From Washington, DC (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - January 18, 2017 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

The Need for Revision in THA -- Merely a 'Bump in the Road'?
For over 40 years, orthopedic surgeon Philip Wilson followed some 300 of his THA patients. His trove of data suggests a new perspective on the need for revision and what constitutes failure in THA. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - January 13, 2017 Category: Rheumatology Authors: Medscape Source Type: podcasts

Leonard H. Calabrese, DO - Recent Advances in the Management of Rheumatoid Arthritis: A Clinical Update From Washington, DC
Recent Advances in the Management of Rheumatoid Arthritis: A Clinical Update From Washington, DC (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - December 31, 2016 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Choosing a Management Strategy in RA
Drs Paget and Bykerk discuss the current data on treatment timing, disease modification, and comorbidities in rheumatoid arthritis. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 30, 2016 Category: Rheumatology Authors: Medscape Source Type: podcasts

Comorbidities in Inflammatory Joint Disease
Drs Paget and Schwartzman discuss both rare and common comorbidities, and the latest strategies to prevent their damaging effects. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 30, 2016 Category: Rheumatology Authors: Medscape Source Type: podcasts

From Washington, an Update on Arthritis and Arteritis
Dr Jonathan Kay discusses highlights from the 2016 American College of Rheumatology annual meeting. (Source: Medscape Rheumatology Podcast)
Source: Medscape Rheumatology Podcast - November 22, 2016 Category: Rheumatology Authors: Medscape Source Type: podcasts

Podcast: Pollution hot spots in coastal waters, extreme bees, and diseased dinos
News stories on bees that live perilously close to the mouth of a volcano, diagnosing arthritis in dinosaur bones, and the evolution of the female orgasm, with David Grimm.   From the magazine Rivers deliver water to the ocean but water is also discharged along the coast in a much more diffuse way. This “submarine groundwater discharge” carries dissolved chemicals out to sea. But the underground nature of these outflows makes them difficult to quantify.  Audrey Sawyer talks with Sarah Crespi about the scale of this discharge and how it affects coastal waters surrounding the United States.   [I...
Source: Science Magazine Podcast - August 4, 2016 Category: Science Authors: Science Tags: Scientific Community Source Type: podcasts

Does Myelofibrosis Worsen Arthritis?
In this Ask the Expert segment, MPN expert Dr. Mark Heaney of Columbia University Medical Center answers Patient Power viewer Candi’s question, “Does myelofibrosis (MF) exacerbate arthritis?” Dr. Hean... Author: patientpower Added: 06/30/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 1, 2016 Category: Cancer & Oncology Source Type: podcasts

Aspirin for ARDS, comparative efficacy of weight loss drugs, review of temporal arteritis and polymyalgia rheumatica, and more
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the June 14, 2016 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - June 14, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Christopher Ritchlin, MD, MPH - Improving Psoriatic Arthritis (PsA) Care Through Enhanced Patient Knowledge and Engagement
Improving Psoriatic Arthritis (PsA) Care Through Enhanced Patient Knowledge and Engagement (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - May 12, 2016 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Jeffrey Curtis, MD, MS, MPH - Recent Advances in the Management of Psoriatic Arthritis: A Clinical Update From San Francisco
Recent Advances in the Management of Psoriatic Arthritis: A Clinical Update From San Francisco (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - March 21, 2016 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Jeffrey Curtis, MD, MS, MPH - Emerging Data in the Treatment of Psoriatic Arthritis and Their Clinical Implications
Emerging Data in the Treatment of Psoriatic Arthritis and Their Clinical Implications (Source: PeerView CME/CE Audio Podcast - Primary Care)
Source: PeerView CME/CE Audio Podcast - Primary Care - March 21, 2016 Category: Primary Care Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts

Effects of naltrexone-buproprion on CV events in obese people, vitamin D for arthritis, predicting postconcussion syndrome in kids, and more
Editor's Audio Summary by Edward H. Livingston, MD, Deputy Editor, the Journal of the American Medical Association, for the March 8, 2016 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - March 8, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

Jeffrey Curtis, MD, MS, MPH - Assessing the Latest Research in Rheumatoid Arthritis Management: Clinical Highlights From San Francisco
Assessing the Latest Research in Rheumatoid Arthritis Management: Clinical Highlights From San Francisco (Source: PeerView CME/CE Audio Podcast - Immunology)
Source: PeerView CME/CE Audio Podcast - Immunology - February 2, 2016 Category: Allergy & Immunology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts